Corporate insider profile
James M Frates Insider Trades
Latest reported as Chief Financial Officer of Amylyx Pharmaceuticals, Inc. (AMLX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$349,820.25
- Latest transaction
- Sep 10, 2026
Affiliated corporations
Reported company relationships
Transaction history
